Goldman Sachs Group, Inc. (The) set a €73.00 ($85.88) target price on Gerresheimer AG (ETR:GXI) in a report released on Friday, July 14th. The firm currently has a neutral rating on the stock.

Other analysts have also issued research reports about the stock. Berenberg Bank set a €83.00 ($97.65) price objective on shares of Gerresheimer AG and gave the company a buy rating in a research note on Thursday, July 13th. Deutsche Bank AG set a €82.00 ($96.47) price objective on shares of Gerresheimer AG and gave the company a buy rating in a research note on Friday, July 7th. J P Morgan Chase & Co set a €99.80 ($117.41) price objective on shares of Gerresheimer AG and gave the company a buy rating in a research note on Wednesday, May 31st. Commerzbank Ag set a €73.00 ($85.88) price target on shares of Gerresheimer AG and gave the stock a neutral rating in a research note on Thursday, July 13th. Finally, Hauck & Aufhaeuser set a €80.00 ($94.12) price target on shares of Gerresheimer AG and gave the stock a neutral rating in a research note on Friday, July 14th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and four have given a buy rating to the stock. Gerresheimer AG currently has an average rating of Hold and a consensus target price of €79.80 ($93.88).

Gerresheimer AG (ETR GXI) traded down 0.378% on Friday, hitting €69.626. 77 shares of the company’s stock traded hands. The stock has a market cap of €2.19 billion and a PE ratio of 19.287. Gerresheimer AG has a one year low of €64.00 and a one year high of €79.47. The stock has a 50-day moving average of €70.53 and a 200-day moving average of €73.00.

ILLEGAL ACTIVITY WARNING: “Goldman Sachs Group, Inc. (The) Analysts Give Gerresheimer AG (GXI) a €73.00 Price Target” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another website, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this story can be viewed at https://www.thecerbatgem.com/2017/08/08/goldman-sachs-group-inc-the-reiterates-73-00-price-target-for-gerresheimer-ag-gxi-updated-updated-updated.html.

About Gerresheimer AG

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer AG (ETR:GXI)

Receive News & Stock Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related stocks with our FREE daily email newsletter.